MONETA GROUP INVESTMENT ADVISORS LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1120927 ST LOUIS, MO

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$444,573

-$180 QoQ

Shares Held

895

-10.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,106

of 1,735 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MONETA GROUP INVESTMENT ADVISORS LLC holds $3,273,847 across 13 Biotechnology names. VRTX ranks #2 (13.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ADAG	Adagene Inc.	200,000	$840,000
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	895	$444,573
3	CORT	Corcept Therapeutics Inc	4,715	$409,969
4	REGN	Regeneron Pharmaceuticals, Inc.	502	$313,017
5	CAI	Caris Life Sciences, Inc.	17,159	$305,773
6	ONC	BeOne Medicines Ltd.	815	$232,250
7	CAPR	Capricor Therapeutics, Inc.	9,399	$226,327
8	CADL	Candel Therapeutics, Inc.	14,525	$149,607

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$444,573	895	-10.1%	Shares	Sole	2026-08-14
2026-03-31	$444,753	996	-10.0%	Shares	Sole	2026-05-12
2025-12-31	$501,869	1,107	-5.9%	Shares	Sole	2026-02-12
2025-09-30	$460,960	1,177	-5.5%	Shares	Sole	2025-11-14
2025-06-30	$554,719	1,246	+6.3%	Shares	Sole	2025-08-14
2025-03-31	$568,209	1,172	+10.6%	Shares	Sole	2025-05-15
2024-12-31	$426,862	1,060	-18.8%	Shares	Sole	2025-02-11
2024-09-30	$607,394	1,306	+3.9%	Shares	Sole	2024-11-12
2024-06-30	$589,181	1,257	-5.9%	Shares	Sole	2024-08-13
2024-03-31	$558,461	1,336	+40.8%	Shares	Sole	2024-08-13
2023-12-31	$386,138	949	+7.2%	Shares	Sole	2024-02-15
2023-09-30	$307,749	885	-10.7%	Shares	Sole	2023-11-15
2023-06-30	$348,742	991	+20.4%	Shares	Sole	2023-08-15
2023-03-31	$259,302	823	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.